| |
---|
| Detailed Price Information Link |
PLASMIDS | |
Name: | pBD8 |
DSM No.: | 4871 dsm-4871 dsm4871 dsm 4871 pBD8 |
Other collection no. or WDCM no.: | BGSC 1E21 |
History: | <- BGSC |
Mol. weight: | 9 kb |
Marker: | Cmr, Kmr, Smr |
Remarks: | General purpose cloning vector. The EcoRI and HindIII sites allow insertional inactivation of the streptomycin resistance gene, and the BglII site lies within the kanamycin resistance gene. |
Distributed in: | Bacillus subtilis subsp. subtilis BD426 (derivative of strain 168) |
Cultivation conditions: | Medium 381, 30°C°C |
Literature: | 3554 |
Risk group: | 1 (classification according to German TRBA) |
Restrictions: | German law regulating genetic engineering / Gentechnikgesetz), Category C
|
Country: | country of origin unknown |
Date of sampling: | before 23.11.1992 |
Nagoya Protocol Restrictions: | There are NO known Nagoya protocol restrictions for this strain. |
Supplied as: | Delivery form | | Organization type | | | | Profit | | Non-Profit | | | Freeze Dried | | 100,- € | | 100,- € | | Active culture on request | | 240,- € | | 240,- € | |
Price category 1 strain. Please see price list for freight and handling charges |
| Print data sheet |